LONDON — The need to develop novel innovative cancer drugs at affordable prices is forcing large pharmaceutical firms to collaborate with biotech companies and academic institutions. Japan-based Takeda Pharmaceuticals too is focusing on strategic collaborations to bolster its global immuno-oncology (IO) footprint, says GlobalData, a leading data and analytics company. In January 2021, Takeda entered
DEERFIELD, Ill. — Trintellix (vortioxetine), a once-daily oral antidepressant indicated for the treatment of major depressive disorder (MDD) in adults, has been rolled out to U.S. pharmacies by Takeda Pharmaceuticals U.S.A. and Lundbeck. The companies recently announced that the trade name for their vortioxetine product in this country would be changed to Trintellix to avoid
DEERFIELD, Ill. — Ramona Sequeira has been appointed president of Takeda Pharmaceuticals U.S.A. Inc., a unit of Takeda Pharmaceutical Co. The company said this week that Sequeira will lead all business operations for the United States and report to Christophe Weber, president and chief executive officer of Takeda. She joins Takeda from her most recent
